Addus HomeCare Corp ADUS

Healthcare SIC 8082 - Services-Home Health Care Services NAICS Health Care and Social Assistance › Ambulatory Health Care Services › Home Health Care Services derived Nasdaq

Addus has been providing home care services since 1979. We operate three segments: personal care, hospice, and home health. Our services are principally provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly "dual eligible," meaning they are eligible to receive both Medicare and Medicaid benefits.

We continue to drive organic growth while also growing through acquisitions, focusing on growth in the states in which we have a presence while adding clinical care services to our offerings. As of December 31, 2025, we provide all three levels of care, personal care, home health and hospice services, in Ohio, Tennessee, Illinois and New Mexico and strategically continue to pursue other markets.

Last close 121.81 2026-10-23
Market cap $2.27B 2026-06-30 share count
52-week range 87.95 - 124.44

Valuation FY2025 figures against the last close

P/S1.6x
P/E23.3x
P/FCF21.9x
EV/EBITDA15.5x
Dividend yield—
Diluted EPS5.22

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.42B$1.15B$1.06B$951.1M$864.5M$764.8M$648.8M$516.6M$426.0M$400.9M
Cost of revenue $960.7M$779.6M$718.8M$651.4M$594.7M$538.5M$469.6M$379.8M$310.1M$294.6M
Gross profit $461.9M$375.0M$339.9M$299.7M$269.8M$226.2M$179.2M$136.8M$115.9M$106.3M
SG&A $306.8M$258.8M$234.8M$216.9M$189.4M$169.7M$133.9M$105.3M$76.9M$76.8M
Total operating expenses $323.3M$272.3M$248.9M$231.0M$203.9M$181.7M$144.5M$114.0M$90.6M$90.9M
Operating income $138.6M$102.7M$91.0M$68.7M$65.9M$44.5M$34.8M$22.8M$25.3M$15.5M
Interest expense ——$11.1M$8.9M$5.8M$3.2M$3.1M$5.0M$4.5M$2.3M
Pre-tax income $127.4M$99.4M$81.3M$60.2M$60.4M$41.9M$33.2M$20.4M$21.1M$16.2M
Income tax $31.5M$25.8M$18.8M$14.1M$15.3M$8.8M$7.4M$4.1M$9.3M$4.1M
Net income $95.9M$73.6M$62.5M$46.0M$45.1M$33.1M$25.2M$16.4M$12.0M$12.2M
EPS, basic 5.314.333.912.902.872.121.831.361.041.07
EPS, diluted 5.224.233.832.842.812.081.771.331.031.07
Shares, diluted (wtd. avg.) 18.4M17.4M16.3M16.2M16.1M16.0M14.2M12.4M11.6M11.3M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents —$98.9M$64.8M$80.0M$168.9M$145.1M$111.7M$70.4M$53.8M$8.0M
Receivables $151.7M$122.9M$115.5M$125.5M$137.0M$132.7M$149.7M$98.3M$93.5M$117.0M
Total current assets $269.5M$260.4M$200.0M$222.8M$324.3M$287.7M$269.4M$176.0M$155.7M$131.0M
Property, plant and equipment $25.0M$24.7M$24.0M$21.2M$18.5M$19.7M$12.2M$10.7M$7.5M$6.6M
Goodwill $996.7M$970.6M$663.0M$582.8M$504.4M$469.1M$275.4M$135.4M$90.3M$72.7M
Other intangibles $102.4M$109.6M$92.0M$72.2M$64.3M$71.5M$57.1M$23.8M$16.6M$15.3M
Total assets $1.44B$1.41B$1.02B$938.0M$947.6M$892.6M$636.7M$348.1M$271.7M$229.9M
Accounts payable $16.8M$27.2M$26.2M$22.1M$19.4M$23.7M$19.6M$12.2M$7.4M$4.5M
Short-term debt —————$971.0K$728.0K$62.0K$3.1M$2.5M
Total current liabilities $149.5M$155.9M$145.1M$131.1M$117.7M$143.9M$87.5M$61.5M$55.1M$49.6M
Long-term debt $121.0M$218.4M$124.1M$131.8M$220.9M$193.9M$59.2M$17.2M$39.9M$22.5M
Total liabilities $352.0M$442.1M$317.7M$304.5M$373.2M$373.9M$161.2M$79.6M$95.4M$72.1M
Retained earnings $472.3M$376.4M$302.8M$240.3M$194.3M$149.2M$116.0M$90.8M$80.3M$65.5M
Total equity $1.09B$970.5M$706.7M$633.5M$574.3M$518.7M$475.6M$268.5M$170.3M$154.7M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $111.5M$116.4M$112.2M$105.1M$39.5M$109.4M$12.0M$33.2M$52.8M-$743.0K
Depreciation and amortisation $16.4M$13.5M$14.1M$14.1M$14.5M$12.1M$10.6M$8.6M$6.7M$6.6M
Stock-based compensation $16.4M$11.2M$10.3M$10.6M$9.4M$6.0M$5.8M$4.1M$2.6M$1.1M
Capital expenditure $7.7M$6.0M$9.5M$8.3M$4.6M$6.8M$4.6M$5.3M$3.6M$1.7M
Investing cash flow -$32.5M-$354.6M-$119.2M-$106.6M-$42.0M-$214.2M-$188.7M-$67.8M-$24.3M-$21.7M
Financing cash flow -$96.3M$272.3M-$8.2M-$87.5M$26.3M$138.2M$218.0M$51.2M$17.2M$26.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-013190.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 500M 1B 1.5B Revenue, FY2016: 400.9M Gross profit, FY2016: 106.3M Net income, FY2016: 12.2M Revenue, FY2017: 426M Gross profit, FY2017: 115.9M Net income, FY2017: 12M Revenue, FY2018: 516.6M Gross profit, FY2018: 136.8M Net income, FY2018: 16.4M Revenue, FY2019: 648.8M Gross profit, FY2019: 179.2M Net income, FY2019: 25.2M Revenue, FY2020: 764.8M Gross profit, FY2020: 226.2M Net income, FY2020: 33.1M Revenue, FY2021: 864.5M Gross profit, FY2021: 269.8M Net income, FY2021: 45.1M Revenue, FY2022: 951.1M Gross profit, FY2022: 299.7M Net income, FY2022: 46M Revenue, FY2023: 1.1B Gross profit, FY2023: 339.9M Net income, FY2023: 62.5M Revenue, FY2024: 1.2B Gross profit, FY2024: 375M Net income, FY2024: 73.6M Revenue, FY2025: 1.4B Gross profit, FY2025: 461.9M Net income, FY2025: 95.9M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $400.9M $426.0M $516.6M $648.8M $764.8M $864.5M $951.1M $1.06B $1.15B $1.42B
Gross profit $106.3M $115.9M $136.8M $179.2M $226.2M $269.8M $299.7M $339.9M $375.0M $461.9M
Net income $12.2M $12.0M $16.4M $25.2M $33.1M $45.1M $46.0M $62.5M $73.6M $95.9M

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8082

TickerCompanyMarket capP/ERevenue growth
BTSG BrightSpring Health Services, Inc. $11.89B 69.1x 28.2%
CHE CHEMED CORP $6.70B 28.0x 4.1%
OPCH Option Care Health, Inc. $4.90B 24.6x 13.0%
AVAH Aveanna Healthcare Holdings, Inc. $2.92B 12.7x 20.2%
AHCO AdaptHealth Corp. $820.8M — -0.5%